1-8 of 8
Amod A. Sarnaik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Available to Purchase
Ahmad A. Tarhini, Zeynep Eroglu, Islam Eljilany, Jonathan S. Zager, Ricardo J. Gonzalez, Amod A. Sarnaik, Carl Wayne Cruse, Nikhil I. Khushalani, Deanryan B. De Aquino, Edith Abraham, Diana M. Acevedo, Allison Richards, Michael J. Schell, Denise Kalos, Pei-Ling Chen, Jane L. Messina, David A. Canton, Vernon K. Sondak
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (23): 5333–5341.
https://doi.org/10.1158/1078-0432.CCR-24-2768
Published: 02 December 2024
View articletitled, Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
Open the PDF for Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Available to Purchase
MacLean S. Hall, John E. Mullinax, Cheryl A. Cox, Amy M. Hall, Matthew S. Beatty, Jamie Blauvelt, Patrick Innamarato, Luz Nagle, Holly Branthoover, Doris Wiener, Benjamin Schachner, Alberto J. Martinez, Allison D. Richards, Carolyn J. Rich, Marjorie Colón Colón, Michael J. Schell, Jamie K. Teer, Nikhil I. Khushalani, Jeffrey S. Weber, James J. Mulé, Vernon K. Sondak, Shari Pilon-Thomas, Amod A. Sarnaik
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5317–5329.
https://doi.org/10.1158/1078-0432.CCR-22-2103
Published: 15 December 2022
View articletitled, Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
Open the PDF for Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Available to Purchase
Jiannong Li, Inna Smalley, Zhihua Chen, Jheng-Yu Wu, Manali S. Phadke, Jamie K. Teer, Thanh Nguyen, Florian A. Karreth, John M. Koomen, Amod A. Sarnaik, Jonathan S. Zager, Nikhil I. Khushalani, Ahmad A. Tarhini, Vernon K. Sondak, Paulo C. Rodriguez, Jane L. Messina, Y. Ann Chen, Keiran S.M. Smalley
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 2131–2146.
https://doi.org/10.1158/1078-0432.CCR-21-3145
Published: 13 May 2022
View articletitled, Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Open the PDF for Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma

Available to Purchase
Caitlin A. Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, Tatiana Karpinets, Katarzyna Tomczak, Chip Stewart, Carlos A. Torres-Cabala, Shari Pilon-Thomas, Amod A. Sarnaik, James J. Mulé, Levi Garraway, Matias Bustos, Jianhua Zhang, Sapna P. Patel, Adi Diab, Isabella C. Glitza, Cassian Yee, Hussein Tawbi, Michael K. Wong, Jennifer McQuade, Dave S.B. Hoon, Michael A. Davies, Patrick Hwu, Rodabe N. Amaria, Cara Haymaker, Rameen Beroukhim, Chantale Bernatchez
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1911–1924.
https://doi.org/10.1158/1078-0432.CCR-21-1060
Published: 02 May 2022
View articletitled, Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma
Open the PDF for Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Free
Cigdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso, Laxminarasimha Donthireddy, Allison Richards, Valerie Moberg, Shari Pilon-Thomas, Michael Schell, Jane L. Messina, Vito W. Rebecca, Min Xiao, Jiufeng Tan, Gao Zhang, Jeffrey S. Weber, Meenhard Herlyn, Amod A. Sarnaik, Dmitry I. Gabrilovich
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (9): 2783–2794.
https://doi.org/10.1158/1078-0432.CCR-18-2725
Published: 01 May 2019
View articletitled, BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Open the PDF for BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells in another window
Includes: Supplementary data
Journal Articles

Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

Free
Jessica Ann Chacon, Amod A. Sarnaik, Jie Qing Chen, Caitlin Creasy, Charuta Kale, John Robinson, Jeffrey Weber, Patrick Hwu, Shari Pilon-Thomas, Laszlo Radvanyi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (3): 611–621.
https://doi.org/10.1158/1078-0432.CCR-14-1934
Published: 01 February 2015
View articletitled, Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Open the PDF for Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in another window
Includes: Supplementary data
Journal Articles

The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms

Free
Kim H.T. Paraiso, H. Eirik Haarberg, Elizabeth Wood, Vito W. Rebecca, Y. Ann Chen, Yun Xiang, Antoni Ribas, Roger S. Lo, Jeffrey S. Weber, Vernon K. Sondak, Jobin K. John, Amod A. Sarnaik, John M. Koomen, Keiran S.M. Smalley
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2502–2514.
https://doi.org/10.1158/1078-0432.CCR-11-2612
Published: 30 April 2012
View articletitled, The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms
Open the PDF for The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms in another window
Includes: Supplementary data
Journal Articles

Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

Free
Amod A. Sarnaik, Bin Yu, Daohai Yu, Dawn Morelli, MacLean Hall, Dilip Bogle, Lulu Yan, Stephan Targan, Jolie Solomon, Geoff Nichol, Michael Yellin, Jeffrey S. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 896–906.
https://doi.org/10.1158/1078-0432.CCR-10-2463
Published: 15 February 2011
View articletitled, Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma
Open the PDF for Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma in another window